Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.

Abstract excerpt

Non-alcoholic fatty liver disease (NAFLD) refers to a disease spectrum, ranging from mere hepatic steatosis to hepatic necroinflammation (NASH, non-alcoholic steatohepatitis). NASH often leads to fibrosis, which can progress to cirrhosis with a high risk of liver failure and hepatocellular carcinoma. The course of NAFLD is highly variable, and only a minority of patients (2-3%) progress to end-stage liver...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Exercise Therapy
• Share to Fatty Acids, Nonesterified
• Share to Fatty Liver